Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000118203 | SCV000152562 | uncertain significance | not provided | 2013-10-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000118203 | SCV001937784 | benign | not provided | 2021-01-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000118203 | SCV002344534 | benign | not provided | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004019648 | SCV005014900 | uncertain significance | Inborn genetic diseases | 2024-01-03 | criteria provided, single submitter | clinical testing | The c.2990C>T (p.A997V) alteration is located in exon 24 (coding exon 24) of the RTTN gene. This alteration results from a C to T substitution at nucleotide position 2990, causing the alanine (A) at amino acid position 997 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003952577 | SCV004772203 | benign | RTTN-related disorder | 2019-12-18 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |